Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Autonomic dysfunction, immune regulation, and multiple sclerosis.
Neurogenic Causes of Detrusor Underactivity.
Co-morbidities increase the risk of disability pension among MS patients: a population-based nationwide cohort study.
Multiple sclerosis influences the precision of the ankle plantarflexon muscular force production.
Does the preclinical evidence for functional remyelination following engraftment into the injured spinal cord support progression to clinical trials?
Resource utilization, costs and treatment patterns of switching and discontinuing treatment of MS patients with high relapse activity.
Metabolic response to epigallocatechin-3-gallate in relapsing-remitting multiple sclerosis: a randomized clinical trial.
Does Nrf2 help nerves to survive?
Impact of MS genetic loci on familial aggregation, clinical phenotype, and disease prediction.
Delayed Liver Function Impairment Secondary to Interferon β-1a Use in Multiple Sclerosis.
Pharmaceutical approval update.
Different Mechanisms of Inflammation Induced in Virus and Autoimmune-Mediated Models of Multiple Sclerosis in C57BL6 Mice.
Proteomic pattern analysis discriminates among multiple sclerosis-related disorders.
White matter integrity in polydrug users in relation to attachment and personality: a controlled diffusion tensor imaging study.
Multi-Stage Mass Spectrometry Analysis of Sugar-Conjugated β-Turn Structures to be Used as Probes in Autoimmune Diseases.
Gray Matter Volume Reduction Is Associated with Cognitive Impairment in Neuromyelitis Optica.
[Therapeutic development for neuromyelitis optica].
Signal transduction and epigenetic mechanisms in the control of microglia activation during neuroinflammation.
Serial magnetic resonance imaging representation in a Baló's concentric sclerosis.
Passively transferred human NMO-IgG exacerbates demyelination in mouse experimental autoimmune encephalomyelitis.
Correction: Predicting Relapsing-Remitting Dynamics in Multiple Sclerosis Using Discrete Distribution Models: A Population Approach.
[Coexistent depressive and anxiety disorders in epilepsy and multiple sclerosis: a challenge to neuropsychiatric practice.]
Three decades of drift: the misdiagnosis of predominantly neuropsychiatric multiple sclerosis.
Association of IL-23 and its receptor gene single nucleotide polymorphisms with Multiple Sclerosis in Chinese Southern Population.
Increased frequency and severity of restless legs syndrome in patients with neuromyelitis optica spectrum disorder.
Pages
« first
‹ previous
…
689
690
691
692
693
694
695
696
697
…
next ›
last »